Tobacco smoke-related diffuse lung diseases

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Cigarette smoking has been associated with several diffuse lung diseases in which both bronchiolar and interstitial lung inflammation appear to result from chronic tobacco smoke inhalation. These diseases occur primarily in relatively young adult smokers and include desquamative interstitial pneumonia, respiratory bronchiolitis-associated interstitial lung disease, and pulmonary Langerhans cell histiocytosis. Although these diseases are associated with characteristic histopathologic and radiological features, there is significant overlap among these diseases, and some smokers may exhibit features indicative of the broad spectrum of smoking-related interstitial and bronchiolar lung injury patterns. Cigarette smoking has also been associated with acute eosinophilic pneumonia, and it increases the risk of developing other fibrotic interstitial lung diseases such as idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease. Although relatively uncommon, these smoking-related diffuse lung diseases should be recognized by clinicians as an important subset in the spectrum of interstitial lung diseases in which smoking cessation forms a central part of disease management. With the exception of acute eosinophilic pneumonia, which responds well to corticosteroid therapy, the role of corticosteroid and other immune-suppressive treatments in the management of smoking-related interstitial lung diseases is not entirely clear and is probably of limited utility, particularly in the absence of smoking cessation.

Original languageEnglish (US)
Pages (from-to)643-650
Number of pages8
JournalSeminars in Respiratory and Critical Care Medicine
Volume29
Issue number6
DOIs
StatePublished - Dec 2008

Fingerprint

Interstitial Lung Diseases
Smoke
Lung Diseases
Tobacco
Smoking
Pulmonary Eosinophilia
Smoking Cessation
Adrenal Cortex Hormones
Idiopathic Pulmonary Fibrosis
Langerhans Cell Histiocytosis
Bronchiolitis
Lung Injury
Disease Management
Inhalation
Young Adult
Rheumatoid Arthritis
Pneumonia
Lung
Therapeutics

Keywords

  • Acute eosinophilic pneumonia
  • Desquamative interstitial pneumonia
  • Interstitial lung disease
  • Pulmonary langerhans cell histiocytosis
  • Respiratory bronchiolitis
  • Smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Tobacco smoke-related diffuse lung diseases. / Vassallo, Robert; Ryu, Jay H.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 29, No. 6, 12.2008, p. 643-650.

Research output: Contribution to journalArticle

@article{f092287542c44a30ad5a726d85775d18,
title = "Tobacco smoke-related diffuse lung diseases",
abstract = "Cigarette smoking has been associated with several diffuse lung diseases in which both bronchiolar and interstitial lung inflammation appear to result from chronic tobacco smoke inhalation. These diseases occur primarily in relatively young adult smokers and include desquamative interstitial pneumonia, respiratory bronchiolitis-associated interstitial lung disease, and pulmonary Langerhans cell histiocytosis. Although these diseases are associated with characteristic histopathologic and radiological features, there is significant overlap among these diseases, and some smokers may exhibit features indicative of the broad spectrum of smoking-related interstitial and bronchiolar lung injury patterns. Cigarette smoking has also been associated with acute eosinophilic pneumonia, and it increases the risk of developing other fibrotic interstitial lung diseases such as idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease. Although relatively uncommon, these smoking-related diffuse lung diseases should be recognized by clinicians as an important subset in the spectrum of interstitial lung diseases in which smoking cessation forms a central part of disease management. With the exception of acute eosinophilic pneumonia, which responds well to corticosteroid therapy, the role of corticosteroid and other immune-suppressive treatments in the management of smoking-related interstitial lung diseases is not entirely clear and is probably of limited utility, particularly in the absence of smoking cessation.",
keywords = "Acute eosinophilic pneumonia, Desquamative interstitial pneumonia, Interstitial lung disease, Pulmonary langerhans cell histiocytosis, Respiratory bronchiolitis, Smoking",
author = "Robert Vassallo and Ryu, {Jay H}",
year = "2008",
month = "12",
doi = "10.1055/s-0028-1101274",
language = "English (US)",
volume = "29",
pages = "643--650",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "6",

}

TY - JOUR

T1 - Tobacco smoke-related diffuse lung diseases

AU - Vassallo, Robert

AU - Ryu, Jay H

PY - 2008/12

Y1 - 2008/12

N2 - Cigarette smoking has been associated with several diffuse lung diseases in which both bronchiolar and interstitial lung inflammation appear to result from chronic tobacco smoke inhalation. These diseases occur primarily in relatively young adult smokers and include desquamative interstitial pneumonia, respiratory bronchiolitis-associated interstitial lung disease, and pulmonary Langerhans cell histiocytosis. Although these diseases are associated with characteristic histopathologic and radiological features, there is significant overlap among these diseases, and some smokers may exhibit features indicative of the broad spectrum of smoking-related interstitial and bronchiolar lung injury patterns. Cigarette smoking has also been associated with acute eosinophilic pneumonia, and it increases the risk of developing other fibrotic interstitial lung diseases such as idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease. Although relatively uncommon, these smoking-related diffuse lung diseases should be recognized by clinicians as an important subset in the spectrum of interstitial lung diseases in which smoking cessation forms a central part of disease management. With the exception of acute eosinophilic pneumonia, which responds well to corticosteroid therapy, the role of corticosteroid and other immune-suppressive treatments in the management of smoking-related interstitial lung diseases is not entirely clear and is probably of limited utility, particularly in the absence of smoking cessation.

AB - Cigarette smoking has been associated with several diffuse lung diseases in which both bronchiolar and interstitial lung inflammation appear to result from chronic tobacco smoke inhalation. These diseases occur primarily in relatively young adult smokers and include desquamative interstitial pneumonia, respiratory bronchiolitis-associated interstitial lung disease, and pulmonary Langerhans cell histiocytosis. Although these diseases are associated with characteristic histopathologic and radiological features, there is significant overlap among these diseases, and some smokers may exhibit features indicative of the broad spectrum of smoking-related interstitial and bronchiolar lung injury patterns. Cigarette smoking has also been associated with acute eosinophilic pneumonia, and it increases the risk of developing other fibrotic interstitial lung diseases such as idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease. Although relatively uncommon, these smoking-related diffuse lung diseases should be recognized by clinicians as an important subset in the spectrum of interstitial lung diseases in which smoking cessation forms a central part of disease management. With the exception of acute eosinophilic pneumonia, which responds well to corticosteroid therapy, the role of corticosteroid and other immune-suppressive treatments in the management of smoking-related interstitial lung diseases is not entirely clear and is probably of limited utility, particularly in the absence of smoking cessation.

KW - Acute eosinophilic pneumonia

KW - Desquamative interstitial pneumonia

KW - Interstitial lung disease

KW - Pulmonary langerhans cell histiocytosis

KW - Respiratory bronchiolitis

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=61849097755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849097755&partnerID=8YFLogxK

U2 - 10.1055/s-0028-1101274

DO - 10.1055/s-0028-1101274

M3 - Article

C2 - 19221962

AN - SCOPUS:61849097755

VL - 29

SP - 643

EP - 650

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 6

ER -